Pharmafile Logo

Webcast: China Update 2023: How will recent developments impact your brand’s success?

May 10, 2023 | China, emerging markets, webinar 

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

- PMLiVE

Wednesday May 31, 2023 – 10:00 – 10:30 EDT / 15:00 BST / 16:00 CEST

For decades, China has had the largest population in the world. However, recent demographic trends have resulted in India being the world’s most populous country. COVID-19, an aging population and low birth rate have all contributed to the decrease in China’s population growth, but what does this really mean to the pharmaceutical industry?

Watch this webcast, in which our in-house experts, Marc Yates and Peggy Yau, explain the impact of the demographic shift, and the new policies that have been introduced. They provide an in-depth understanding of the pharma landscape in China which offers exciting potential, such as the breakthrough of biosimilars, the vaccination boom and Healthy China 2030 policy. The presenters further showcase where to play and how to win, providing examples spanning from market access to clinical trial design and patient journey research.

What are the takeaways?

  • Learn about the implications of the changing demographics on the healthcare landscape
  • Discover Research Partnership’s take on ‘where to play, how to win’ in China
  • Understand how to maximize your market research across key stakeholder groups in China

Watch here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.